Literature DB >> 15735198

Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27.

Michael Cusick1, Annal D Meleth, Elvira Agrón, Marion R Fisher, George F Reed, Genell L Knatterud, Franca B Barton, Matthew D Davis, Frederick L Ferris, Emily Y Chew.   

Abstract

OBJECTIVE: Diabetes is a leading cause of morbidity and mortality. The purpose of this study is to assess the associations between diabetes complications and mortality in the Early Treatment Diabetic Retinopathy Study (ETDRS). RESEARCH DESIGN AND METHODS: We examined demographic, clinical, and laboratory characteristics of the 3,711 subjects enrolled in the ETDRS, a randomized controlled clinical trial designed to evaluate the role of laser photocoagulation and aspirin therapy for diabetic retinopathy. The outcome assessed was all-cause mortality. Multivariable Cox proportional hazards regression was used to assess associations between diabetes complications and mortality for type 1 and type 2 diabetes separately.
RESULTS: The 5-year estimates of all-cause mortality were 5.5 and 18.9% for patients with type 1 and type 2 diabetes, respectively. In patients with type 1 diabetes, amputation (hazard ratio [HR] 5.08 [95% CI 2.06-12.54]) and poor visual acuity (1.74 [1.10-2.75]) remained significantly associated with mortality, after adjusting for other diabetes complications and baseline characteristics. In patients with type 2 diabetes, macrovascular disease and worsening levels of nephropathy, neuropathy, retinopathy, and visual acuity are associated with progressively increasing risks of mortality, after controlling for other baseline risk factors.
CONCLUSIONS: Amputation is the strongest predictor for mortality in patients with type 1 diabetes. All complications independently predict mortality in patients with type 2 diabetes. There is an increased risk for mortality as the degree of each complication worsens. Additional studies are needed to investigate the effectiveness of tertiary prevention to decrease mortality in these patients.

Entities:  

Mesh:

Year:  2005        PMID: 15735198     DOI: 10.2337/diacare.28.3.617

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  41 in total

1.  Receipt of care and reduction of lower extremity amputations in a nationally representative sample of U.S. Elderly.

Authors:  Frank A Sloan; Mark N Feinglos; Daniel S Grossman
Journal:  Health Serv Res       Date:  2010-08-16       Impact factor: 3.402

2.  Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada.

Authors:  R Brett McQueen; Marc D Breton; Markus Ott; Helena Koa; Bruce Beamer; Jonathan D Campbell
Journal:  J Diabetes Sci Technol       Date:  2015-08-14

Review 3.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

4.  Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  Rodica Pop-Busui; Gregory W Evans; Hertzel C Gerstein; Vivian Fonseca; Jerome L Fleg; Byron J Hoogwerf; Saul Genuth; Richard H Grimm; Marshall A Corson; Ronald Prineas
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 19.112

5.  Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia.

Authors:  Mario Azevedo; Sridevi Alla
Journal:  Int J Diabetes Dev Ctries       Date:  2008-10

6.  Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method.

Authors:  Betty Tao; Massimo Pietropaolo; Mark Atkinson; Desmond Schatz; David Taylor
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

7.  Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark.

Authors:  J Grauslund; A Green; A K Sjølie
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122

8.  Levels of three distinct p75 neurotrophin receptor forms found in human plasma are altered in type 2 diabetic patients.

Authors:  P M Humpert; S Kopf; Z Djuric; K Laine; G Korosoglou; G Rudofsky; A Hamann; M Morcos; M von Eynatten; P P Nawroth; A Bierhaus
Journal:  Diabetologia       Date:  2007-05-11       Impact factor: 10.122

9.  Clinico-microbiological study and antibiotic resistance profile of mecA and ESBL gene prevalence in patients with diabetic foot infections.

Authors:  Waqas Nasir Chaudhry; Rabia Badar; Muhsin Jamal; Jason Jeong; Jamal Zafar; Saadia Andleeb
Journal:  Exp Ther Med       Date:  2016-01-14       Impact factor: 2.447

10.  Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  Jorge Calles-Escandón; Laura C Lovato; Denise G Simons-Morton; David M Kendall; Rodica Pop-Busui; Robert M Cohen; Denise E Bonds; Vivian A Fonseca; Faramarz Ismail-Beigi; Mary Ann Banerji; Alan Failor; Bruce Hamilton
Journal:  Diabetes Care       Date:  2010-01-26       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.